Research archive

Christine M. Klaskin

Christine M. Klaskin, Vice President, Finance (resigned effective December 31, 2025) at Agenus Inc.. Biography, career history and compensation sourced from Agenus Inc. proxy statement (SEC Schedule 14A).

About

Christine M. Klaskin served as Agenus's Vice President of Finance and was a named executive officer for 2025; she resigned effective December 31, 2025. A portion of her salary in both 2025 and 2024 ($29,822) was allocated for services provided to Agenus affiliate MiNK Therapeutics and is also reported in MiNK's compensation disclosures.

She also signed Agenus's SEC filings in her capacity as Vice President of Finance.

Roles

Agenus Inc.

Vice President, Finance (resigned effective December 31, 2025) · Current role

Present

Fixed Compensation

FY 2025

Salary

$298,224

Note$29,822 allocated to services for MiNK Therapeutics

All Other Compensation

$6,538

Total

$332,019

Performance Compensation

Data from FY 2025

Cash incentive

Annual incentive bonus

$0

Target Opportunity

—

NoteNot eligible for a 2025 bonus

Stock awards

Option Awards

$27,257

BasisGrant-date fair value, ASC Topic 718

Director Compensation

Also at Agenus Inc.

Founder, Chairman & Chief Executive Officer (also interim Principal Financial Officer)

Director; Chairman of the Executive Council

Director; Chair of Compensation Committee and Executive Committee

Related

Agenus 4 Antibody

Agenus Celexion Antibody Discovery Assets

See how Top Bucket AI works for your firm

Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.

Dated reference snapshot as of September 10, 2026. This is not a live financial feed. Verify figures against primary filings before relying on them.